Absci (ABSI) Shares Outstanding (Diluted Average) (2020 - 2026)
Absci's (ABSI) quarterly Shares Outstanding (Diluted Average) came in at $153.0 million in Q1 2026, up 22.9% year-on-year from $124.5 million in Q1 2025, and up 11.83% quarter-over-quarter from $136.8 million in Q4 2025.
Absci (ABSI) Shares Outstanding (Diluted Average) (2020 - 2026) Analysis & Trends
Absci has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $153.0 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $153.0 million, up 22.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.0 million (up 22.9% YoY), and the FY2025 annual result was $136.8 million, up 24.07% from the prior year.
- Shares Outstanding (Diluted Average) came in at $153.0 million for Q1 2026 at Absci, up from $136.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $153.0 million in Q1 2026 to a low of $90.3 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $99.4 million (2024), against an average of $107.8 million.
- Across the five-year window, Shares Outstanding (Diluted Average) surged 431.64% in 2022 and gained 0.81% in 2023, its largest moves.
- Absci's Shares Outstanding (Diluted Average) stood at $90.8 million in 2022, then increased by 1.3% to $92.0 million in 2023, then rose by 19.79% to $110.2 million in 2024, then gained by 24.07% to $136.8 million in 2025, then grew by 11.83% to $153.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $153.0 million (Q1 2026), $136.8 million (Q4 2025), and $132.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 152.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 152.96 Mn |
| Dec 31, 2025 | 136.78 Mn |
| Sep 30, 2025 | 132.11 Mn |
| Jun 30, 2025 | 127.59 Mn |
| Mar 31, 2025 | 124.46 Mn |
| Dec 31, 2024 | 110.24 Mn |
| Sep 30, 2024 | 113.61 Mn |
| Jun 30, 2024 | 106.16 Mn |
| Mar 31, 2024 | 99.39 Mn |
| Dec 31, 2023 | 92.03 Mn |
| Sep 30, 2023 | 91.84 Mn |
| Jun 30, 2023 | 91.83 Mn |
| Mar 31, 2023 | 91.48 Mn |
| Dec 31, 2022 | 90.85 Mn |
| Sep 30, 2022 | 91.11 Mn |
| Jun 30, 2022 | 90.67 Mn |
| Mar 31, 2022 | 90.27 Mn |
| Dec 31, 2021 | 49.69 Mn |
| Sep 30, 2021 | 36.18 Mn |
| Jun 30, 2021 | 17.31 Mn |